Nosocomial fungal infections: epidemiology, diagnosis, and treatment

Area of Science:

• Medicine
• Infectious Diseases
• Mycology

Background:

• Invasive fungal infections (IFIs) are a growing concern in healthcare settings.
• Risk factors for IFIs are increasing, predicting a continued rise in cases.
• Common pathogens include Candida, Aspergillus, Mucorales, Fusarium, and Scedosporium species.

Purpose of the Study:

• To review the current landscape of nosocomial fungal infections.
• To highlight challenges in diagnosis and treatment.
• To discuss the impact of new antifungal agents and future needs.

Main Methods:

• Literature review of recent studies on nosocomial fungal infections.
• Analysis of epidemiological trends and risk factors.
• Evaluation of current and emerging antifungal therapies.

Main Results:

• Nosocomial IFIs are increasingly prevalent and associated with significant morbidity and mortality.
• Diagnosis remains challenging, and outcomes are often poor despite available antifungal therapies.
• New antifungal agents have altered treatment standards, but mortality rates remain high.

Conclusions:

• Effective antifungal therapy and addressing host factors are crucial for managing IFIs.
• Despite advances, mortality from nosocomial fungal infections remains unacceptably high.
• There is an urgent need for innovative therapeutic and preventative strategies to combat these infections.